Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| club cell | 10 studies | 31% ± 11% | |
| goblet cell | 9 studies | 31% ± 13% | |
| endothelial cell of lymphatic vessel | 8 studies | 25% ± 10% | |
| epithelial cell | 8 studies | 26% ± 8% | |
| respiratory goblet cell | 7 studies | 40% ± 12% | |
| endothelial cell | 6 studies | 21% ± 6% | |
| basal cell | 5 studies | 26% ± 15% | |
| ciliated cell | 4 studies | 24% ± 10% | |
| duct epithelial cell | 4 studies | 36% ± 12% | |
| secretory cell | 4 studies | 33% ± 12% | |
| mucus secreting cell | 4 studies | 42% ± 13% | |
| luminal hormone-sensing cell of mammary gland | 4 studies | 48% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| breast | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 4094.76 | 236 / 245 | 99% | 71.26 | 496 / 502 |
| breast | 100% | 6384.00 | 458 / 459 | 94% | 53.08 | 1046 / 1118 |
| pancreas | 100% | 7870.06 | 328 / 328 | 89% | 35.93 | 159 / 178 |
| stomach | 88% | 4464.82 | 317 / 359 | 93% | 28.29 | 267 / 286 |
| intestine | 73% | 2216.84 | 701 / 966 | 95% | 33.27 | 501 / 527 |
| kidney | 99% | 1226.65 | 88 / 89 | 61% | 10.52 | 552 / 901 |
| lung | 99% | 1412.84 | 571 / 578 | 59% | 15.52 | 681 / 1155 |
| bladder | 71% | 1489.90 | 15 / 21 | 75% | 24.95 | 377 / 504 |
| uterus | 88% | 574.99 | 149 / 170 | 49% | 19.07 | 224 / 459 |
| thymus | 93% | 706.66 | 605 / 653 | 43% | 5.25 | 259 / 605 |
| adrenal gland | 94% | 676.28 | 243 / 258 | 23% | 3.56 | 53 / 230 |
| ovary | 19% | 82.13 | 35 / 180 | 86% | 23.87 | 371 / 430 |
| esophagus | 53% | 358.89 | 772 / 1445 | 48% | 13.48 | 87 / 183 |
| spleen | 100% | 1517.98 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 151.96 | 1 / 1 |
| adipose | 99% | 1243.62 | 1188 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 982.90 | 846 / 861 | 0% | 0 | 0 / 0 |
| skin | 66% | 1208.55 | 1190 / 1809 | 4% | 0.62 | 17 / 472 |
| peripheral blood | 63% | 382.89 | 582 / 929 | 0% | 0 | 0 / 0 |
| liver | 15% | 72.35 | 34 / 226 | 25% | 5.01 | 100 / 406 |
| blood vessel | 29% | 155.96 | 393 / 1335 | 0% | 0 | 0 / 0 |
| brain | 26% | 116.96 | 695 / 2642 | 1% | 0.18 | 10 / 705 |
| muscle | 26% | 107.63 | 207 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 5.49 | 7 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.69 | 3 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_2001256 | Biological process | regulation of store-operated calcium entry |
| GO_0002115 | Biological process | store-operated calcium entry |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CRACR2B |
| Protein name | Calcium release activated channel regulator 2B EF-hand calcium-binding domain-containing protein 4A (Calcium release-activated calcium channel regulator 2B) (CRAC channel regulator 2B) (Calcium release-activated channel regulator 2B) |
| Synonyms | EFCAB4A |
| Description | FUNCTION: Plays a role in store-operated Ca(2+) entry (SOCE). . |
| Accessions | Q8N4Y2 ENST00000528315.1 ENST00000528542.6 [Q8N4Y2-3] ENST00000530183.1 E9PK04 ENST00000527089.5 ENST00000525077.2 [Q8N4Y2-1] ENST00000533803.1 E9PPF3 E9PHZ8 E9PRE5 ENST00000450448.5 [Q8N4Y2-3] |